Accendra Health Inc (ACH)

Oct 09, 2026

New Strong Sell Stocks for October 9th - Zacks Investment Research

Oct 09, 2026

Oct 06, 2026

Form 4 Accendra Health Inc For: 6 October By Investing.com - Investing.com Nigeria

Oct 06, 2026

Oct 06, 2026

A 283,554-share grant to Accendra Health (ACH) CEO vests one-third annually over three years. - Stock Titan

Oct 06, 2026

Oct 06, 2026

Form 4 ACCENDRA HEALTH INC/VA/ For: Oct 05 Filed by: Gardner-Smith Kenneth - StreetInsider

Oct 06, 2026

Oct 06, 2026

New Strong Sell Stocks for October 6th - Zacks Investment Research

Oct 06, 2026

Sep 28, 2026

Lobbying Update: $200,000 of ACCENDRA HEALTH INC. lobbying was just disclosed - Quiver Quantitative

Sep 28, 2026

Sep 28, 2026

Accendra Health Inc Revenue Breakdown – DUS:6OM - tradingview.com

Sep 28, 2026

Sep 26, 2026

Accendra Health, Inc. $ACH Shares Newly Bought by Bank of America Corp DE - MarketBeat

Sep 26, 2026

Sep 25, 2026

Accendra Health (NYSE:ACH) Stock Forecast & Analyst Predictions - Simply Wall Street

Sep 25, 2026

Sep 24, 2026

Accendra Health (ACH) CFO surrenders shares for taxes tied to stock vesting; he holds 286,268 shares afterward. - Stock Titan

Sep 24, 2026

Sep 20, 2026

Accendra Health names new CEO, chief commercial officer - Richmond Times-Dispatch

Sep 20, 2026

Sep 18, 2026

Accendra Health appoints new CEO and commercial chief - The Globe and Mail

Sep 18, 2026

Sep 17, 2026

Accendra Health Names Kenneth Gardner-Smith CEO, Adds Chief Commercial Officer - citybiz

Sep 17, 2026

Sep 17, 2026

Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth - Business Wire

Sep 17, 2026

Sep 16, 2026

Accendra Health Inc. (ACH) Slips 3.15% to $1.07 as Shares Drift Toward Lower SupportStraddle Setup - careplusvn.com

Sep 16, 2026

Aug 30, 2026

Accendra Health (ACH) Holds Steady at $1.21 as Shares Trade Within Defined Support and Resistance Range - siam.in

Aug 30, 2026

Aug 28, 2026

Connor Clark & Lunn Investment Management Ltd. Invests $4.41 Million in Accendra Health, Inc. $ACH - MarketBeat

Aug 28, 2026

Aug 25, 2026

2,536,699 Shares in Accendra Health, Inc. $ACH Purchased by Paradigm Capital Management Inc. NY - MarketBeat

Aug 25, 2026

Aug 24, 2026

Accendra (ACH) Latest Quarter: EPS Does Not Reach the Reported Estimate in the Reported Period; Closing Reaction: The Share Price Sheds 4.67% at the CloseEarnings Surprise Report - vinanet.vn

Aug 24, 2026

Aug 19, 2026

Accendra (ACH) Quarterly Figures: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Stock Move: The Stock Gains 5.61% for the Current SessionBasic EPS Analysis - vinanet.vn

Aug 19, 2026

Aug 17, 2026

Accendra Health scraps equity program, expects CEO successor By Investing.com - Investing.com South Africa

Aug 17, 2026

Aug 17, 2026

Accendra Health Inc (ACH) (Q2 2026) Earnings Call Highlights: Na - GuruFocus

Aug 17, 2026

Aug 17, 2026

Accendra Health provides update on CEO transition, credit facility - HME News

Aug 17, 2026

Aug 17, 2026

Accendra Health Drops Equity Issuance Plan, Targets September CEO Announcement - citybiz

Aug 17, 2026

Aug 17, 2026

Accendra Health drops equity issuance plan as CEO succession process advances - Yahoo Finance

Aug 17, 2026

Aug 17, 2026

Accendra Health scraps equity program, expects CEO successor - Investing.com

Aug 17, 2026

Aug 17, 2026

Form 8K Accendra Health Inc For: 17 August By Investing.com - Investing.com Nigeria

Aug 17, 2026

Aug 17, 2026

Accendra Health sells first of two non-core assets, expects about $45 million cash injection - Bitget

Aug 17, 2026

Aug 17, 2026

Form 8K Accendra Health Inc For: 17 August By Investing.com - Investing.com India

Aug 17, 2026

Aug 17, 2026

Form 8K Accendra Health Inc For: 17 August By Investing.com - Investing.com Canada

Aug 17, 2026

Aug 17, 2026

Form 8K Accendra Health Inc For: 17 August By Investing.com - Investing.com UK

Aug 17, 2026

Aug 17, 2026

Accendra Health scraps equity program, expects CEO successor By Investing.com - Investing.com Canada

Aug 17, 2026

Aug 17, 2026

Accendra Health to forgo ATM program, sees ~$45M from two asset sales; CEO successor expected by mid-September - TradingView

Aug 17, 2026

Aug 17, 2026

Accendra Health scraps equity program, expects CEO successor By Investing.com - Investing.com India

Aug 17, 2026

Aug 17, 2026

Accendra Health scraps equity program, expects CEO successor By Investing.com - Investing.com UK

Aug 17, 2026

Aug 17, 2026

Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans - Yahoo Finance

Aug 17, 2026

Aug 14, 2026

Accendra Health ready to put weak Q2 in rear view - HME News

Aug 14, 2026

Aug 14, 2026

Accendra Health (ACH) Drops 9% to $1.10 as Selling Pressure PersistsAnchored VWAP - vinanet.vn

Aug 14, 2026

Aug 12, 2026

Accendra Health (NYSE:ACH) Rating Lowered to "Hold" at Robert W. Baird - MarketBeat

Aug 12, 2026

Aug 12, 2026

Dimensional Fund Advisors LP Buys Shares of 2,606,620 Accendra Health, Inc. $ACH - MarketBeat

Aug 12, 2026

Aug 11, 2026

Accendra Health, Inc. (ACH) stock price, news, quote and history - Yahoo Finance UK

Aug 11, 2026

Aug 11, 2026

Baird downgrades Accendra Health stock rating on weak results By Investing.com - Investing.com South Africa

Aug 11, 2026

Aug 11, 2026

Accendra Health, Inc. (ACH) Stock Price, News, Quote & History - Yahoo! Finance Canada

Aug 11, 2026

Aug 11, 2026

Baird downgrades Accendra Health stock rating on weak results By Investing.com - Investing.com UK

Aug 11, 2026

Aug 11, 2026

Accendra Health adopts tax asset preservation plan - HME News

Aug 11, 2026

Aug 11, 2026

Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search - marketscreener.com

Aug 11, 2026

Aug 11, 2026

Citigroup Downgrades Accendra Health to Neutral From Buy, Adjusts PT to $1.50 From $4.50 - marketscreener.com

Aug 11, 2026

Aug 11, 2026

Baird Downgrades Accendra Health to Neutral From Outperform, Adjusts PT to $1.50 From $6 - marketscreener.com

Aug 11, 2026

Aug 11, 2026

ACCENDRA HEALTH INC : BAIRD CUTS TO NEUTRAL RATING; CUTS TARGET PRICE TO $1.5 FROM $6 - Bitget

Aug 11, 2026

Aug 11, 2026

Baird downgrades Accendra Health stock rating on weak results - Investing.com

Aug 11, 2026